推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 原標題：去年下半年草甘膦產(chǎn)業(yè)回暖受益江山股份2016年業(yè)績大增
南通江山農(nóng)藥化工股份有限公司(以下簡稱“江山股份”)發(fā)布2016年年度報告，稱2016年實現(xiàn)營業(yè)收入47.5億元，同比增長77.5%(包含商品銷售業(yè)務收入)；實現(xiàn)歸屬母公司股東凈利潤5,238萬元，同比增長396%。
業(yè)績增長主要原因：草甘膦下半年復蘇，酰胺類、雙敵等表現(xiàn)穩(wěn)健農(nóng)藥方面，公司主導產(chǎn)品草甘膦自16年下半年開始復蘇，至報告期末價格漲幅超過50%。全年草甘膦實現(xiàn)收入15.3億元，受上半年行業(yè)低迷影響，全年毛利率-1.9%；非草甘膦農(nóng)藥方面，酰胺類除草劑、敵敵畏、敵百蟲等產(chǎn)品報告期內(nèi)價格總體穩(wěn)定，公司憑借清潔環(huán)保的工藝優(yōu)勢在行業(yè)內(nèi)競爭對手減少的情況下，提升產(chǎn)能利用率和市場份額，取得較好表現(xiàn)。
據(jù)悉，江山股份是國內(nèi)最大的草甘膦生產(chǎn)企業(yè)之一，擁有草甘膦原藥產(chǎn)能7萬噸/年，其中甘氨酸路線產(chǎn)能3萬噸/年，IDAN路線產(chǎn)能4萬噸/年。公司研制的IDAN法草甘膦生產(chǎn)工藝，產(chǎn)品質量、含量位居行業(yè)前列。
